AVBP
ArriVent BioPharma, Inc.
13.51
+0.02 (+0.11%)
52w low 11.36
35.83 high
8.8% of range
Financial Analysis
| Ratio | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Returns | |||||
| Return on Equity | 43.4% | 45.3% | -31.2% | -54.1% | |
| Return on Assets | -20.2% | -42.5% | -29.3% | -49.9% | |
| Return on Inv Capital | 34.3% | 38.5% | -28.9% | -45.7% | |
| Liquidity | |||||
| Current Ratio | 21.84x | 13.76x | 13.14x | 12.83x | |
| Quick Ratio | 21.84x | 13.76x | 13.14x | 12.83x | |
| Cash Ratio | 19.54x | 12.94x | 4.30x | 1.76x | |
| Leverage | |||||
| Debt / Equity | -0.00x | -0.00x | 0.00x | 0.00x | |
| Equity Multiplier | -2.15x | -1.06x | 1.07x | 1.08x | |
| Efficiency | |||||
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | |
| Op CF / Net Income | 1.18x | 0.81x | 0.87x | 0.97x | |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--